Complete radiological response after sorafenib treatment for advanced hepato-cellular carcinoma

Introduction: Sorafenib, an oral multikinase inhibitor, has recently been shown to improve overall survival in patients with advanced hepatocellular carcinoma [HCC] but only a handful of reports of complete remission on sorafenib have been issued

Case report: We report an intriguing case of advanced HCC complicating HCV infection with cirrhosis, in which the patient achieved complete remission by prolonged administration of sorafenib

Conclusion: Identifying factors that could be associated with good response to this therapy are needed